Kipuwex has developed an innovative solution to address pain assessment challenges in patients who are unable to communicate, such as small children and those with mental disorders. Their technology uses advanced sensors and algorithms to monitor physiological vitals, including heart rate, respiratory patterns, blood pressure, and temperature, along with behavioral indicators like cry and movement. This comprehensive approach allows for objective pain detection and accurate assessments. Kipuwex ensures the reliability of its data through clinical validation, continuous monitoring, cross-validation, user training, and feedback loops. The device is designed with user-friendly interfaces for both healthcare professionals and home users, and it integrates seamlessly with existing healthcare systems. Kipuwex is backed by clinical evidence demonstrating its effectiveness in improving pain management outcomes, particularly in pediatric settings. Future developments aim to further enhance its functionality and impact on pain management, with plans for FDA approval and global distribution.

Advanced Solutions

We started the interview by asking, “How does Kipuwex address the challenges associated with pain assessment in patients who are unable to communicate, such as small children and those with mental disorders?”

Marko Höynälä replied, “Kipuwex addresses the challenges associated with pain assessment in patients who are unable to communicate through innovative technology and comprehensive monitoring solutions. For small children, babies and under 7 years old, who may have difficulty expressing their pain, Kipuwex’s devices utilize advanced sensors and algorithms to monitor physiological vitals and detect pain indicators objectively. By analyzing factors such as heart rate variability, respiratory patterns, and other vital signs, Kipuwex can provide healthcare professionals with valuable insights into a patient’s pain level, enabling more accurate assessment and timely intervention. Through its commitment to improving pain management practices, Kipuwex aims to enhance the quality of life for patients who face communication challenges in expressing their pain.”

Key Physiological Vitals

The Worlds Times: Could you explain the specific physiological vitals that Kipuwex measures to assess pain in patients?

Marko Höynälä replied,  “By simultaneously monitoring the 11 vitals with the assistance of AI, we have the capacity to provide a more nuanced and accurate evaluation of a children’s  pain level.

Pain assessment is a critical aspect of patient care, and the ability to consider multiple biomarkers together allows for a more holistic understanding of the patient’s pain experience. These vitals, including physiological indicators like heart rate, respiratory rate, blood pressure, and temperature and behavioral indicators such as cry and movement can provide valuable insights into a patient’s pain, both its intensity and its impact on their overall health.

Our AI-driven approach to pain assessment not only aids in more precise pain management but also contributes to a better understanding of the patient’s pain experience over time. This holistic approach to pain assessment is especially valuable in the context of chronic pain management, post-operative care, and for patients with complex health conditions.

Our pain assessment solution is targeted for children under the age of 7 and it’s based on manual pain scales Niapas and Flacc pain scale tools.

The FLACC Pain Scale is a tool used to assess pain in individuals who may have difficulty communicating their pain, such as infants, young children, and individuals with cognitive impairments. The FLACC scale stands for:

F – Face: Assess the child’s facial expression. Look for signs of grimacing, frowning, or other facial expressions that indicate pain.

L – Legs: Observe the child’s leg movements. Are they kicking or jerking? Restlessness or tensing of the legs can be indicative of pain.

A – Activity: Take note of the child’s overall body movements. Is the child unusually quiet and still or unusually agitated and active? Changes in activity level can be a sign of pain.

C – Cry: Listen to the child’s vocalizations. Are they crying, whimpering, or making distress sounds? The type and intensity of crying can provide insights into their pain.

C – Consolability: Assess how easily the child can be comforted. If the child is difficult to console or comfort, it may suggest they are in pain.

Each category is typically scored on a scale from 0 to 2, with 0 indicating no pain, 1 indicating moderate pain, and 2 indicating severe pain. The scores from each category are then added together to provide an overall pain assessment, with a maximum total score of 10.

The FLACC Pain Scale is a valuable tool for healthcare professionals to quickly and objectively assess pain in non-verbal patients and make informed decisions about pain management. It’s commonly used in pediatric settings and for individuals with cognitive impairments to ensure that their pain is recognized and treated appropriately.”

Ensuring Precision and Reliability

The Worlds Times: How does Kipuwex ensure the accuracy and reliability of its pain data, especially in critical care settings?

Marko Höynälä replied, “Kipuwex ensures the accuracy and reliability of its pain data, particularly for children under 7 years old, through the following measures:

Clinical Validation: We conduct rigorous clinical studies, including diverse patient populations in critical care settings, comparing Kipuwex data with established pain assessment methods to validate accuracy.

Continuous Monitoring: Our devices undergo continuous monitoring and calibration to maintain accuracy, with regular quality assurance checks and software updates addressing any identified issues.

Cross-Validation: Pain data is cross-validated against multiple physiological vitals and behavioral indicators to ensure consistency and reliability across different modalities.

User Training: We provide comprehensive training to healthcare professionals to use our devices effectively and interpret pain data accurately, ensuring informed clinical decisions.

Feedback Loop: Actively seeking feedback from healthcare professionals and patients allows us to refine our technology, remaining responsive to evolving user needs and enhancing data accuracy and reliability over time.”

Kipuwex’s Uniqueness & Pain Measurement Algorithm

The Worlds Times: Can you describe the algorithm used by Kipuwex to convert physiological data into pain measurements?

Marko Höynälä replied, “Specific details of Kipuwex’s algorithm used to convert physiological data into pain measurements are proprietary and considered a trade secret.”

Then we asked, “What sets Kipuwex apart from other pain assessment devices currently available in the market?”

Marko Höynälä answered, “Kipuwex stands out from other pain assessment devices in the market due to its unique focus on measuring pain specifically in children. While there are devices available for assessing pain in adults, there is currently a gap in the market for pediatric pain assessment tools. Kipuwex fills this gap by providing a dedicated solution designed to accurately measure pain levels in children, particularly those under 7 years old.

Our innovative technology utilizes advanced sensors and algorithms tailored to the physiological and behavioral indicators of pain in pediatric patients. By focusing exclusively on this demographic, Kipuwex ensures that healthcare professionals have access to reliable and accurate pain assessment data for young patients, enabling timely interventions and improved patient care outcomes.

In addition to our specialized focus on pediatric pain assessment, Kipuwex also offers the following distinguishing features:

Comprehensive Data Analysis: Kipuwex analyzes a range of physiological vitals and behavioral indicators to provide a holistic understanding of pain levels in children, enhancing the accuracy and reliability of our assessments.

User-Friendly Interface: Our devices are designed with healthcare professionals in mind, featuring intuitive interfaces and customizable settings to streamline the pain assessment process and facilitate informed clinical decisions.

Continuous Innovation: Kipuwex is committed to ongoing research and development, continuously refining our technology to meet the evolving needs of pediatric patients and healthcare providers.

Overall, Kipuwex’s dedication to pediatric pain assessment, coupled with our commitment to innovation and excellence sets us apart as a leader in the field of pediatric healthcare.”

Pain Assessment Adaptation

The Worlds Times: How does Kipuwex adapt its measurements for different patient populations, such as premature babies whose central nervous systems are still developing?

Marko Höynälä replied, “Kipuwex adapts its pain assessments including premature babies with developing central nervous systems, by simultaneously monitoring 11 vitals with AI assistance. This comprehensive approach provides a nuanced and accurate evaluation of a child’s pain level, considering physiological indicators like heart rate, respiratory rate, blood pressure, and temperature, as well as behavioral indicators such as cry and movement. Our solution is based on manual pain scales like Niapas and Flacc, which assess facial expressions, leg movements, activity level, cry, and consolability to provide an overall pain assessment score. This holistic approach ensures that pain in non-verbal patients, including infants and individuals with cognitive impairments, is recognized and treated appropriately.”

User Interface Design

The Worlds Times: Can you discuss the usability and user interface of Kipuwex for both healthcare professionals and home users?

Marko Höynälä replied, “Kipuwex prioritizes usability and user interface design tailored to the specific needs. Initially launching for healthcare professionals, the next phase will focus on home users.

For Healthcare Professionals:

Advanced Interface: Kipuwex offers a sophisticated user interface designed for healthcare professionals, providing detailed pain assessment data and advanced functionalities to support clinical decision-making.

Customization Options: Healthcare professionals have access to customizable settings and advanced features to tailor the device to their specific clinical needs and preferences.

Integration Capabilities: Kipuwex seamlessly integrates with existing healthcare systems and electronic medical records, enhancing workflow efficiency and data management.

Training and Support: Comprehensive training and support are provided to healthcare professionals to ensure proficiency in using Kipuwex effectively in clinical settings.

For Home Users: Simplified Interface: Kipuwex offers a simplified and user-friendly interface for home users, prioritizing ease of use and clarity of information.

Intuitive Design: The home user interface features clear instructions and intuitive navigation, making it accessible to caregivers and family members without extensive medical training.

Remote Monitoring: Home users can remotely monitor pain levels and vital signs with ease, receiving alerts and notifications for timely interventions.

Accessibility Features: Kipuwex includes accessibility features to accommodate users with diverse needs, ensuring inclusivity and ease of use for all.

By tailoring the user interface to the specific requirements of healthcare professionals and home users, Kipuwex ensures optimal usability and effectiveness in diverse settings, ultimately enhancing patient care and outcomes.”

Validation through Clinical Trials

The Worlds Times: What evidence or studies support the effectiveness of Kipuwex in improving pain management outcomes?

Marko Höynälä replied, “Kipuwex is supported by a growing body of evidence and studies demonstrating its effectiveness in improving pain management outcomes. Clinical trials and research studies have consistently shown positive results in various healthcare settings, including hospitals, clinics.”

Seamless Integration & Real-World Impact

The Worlds Times: How does Kipuwex integrate with existing healthcare systems or workflows to enhance pain assessment and management?

Marko Höynälä replied, “Kipuwex is seamlessly designed to integrate with existing healthcare systems and workflows, enhancing pain assessment and management with ease. Our device is engineered to be compatible with all hospital healthcare systems, allowing for smooth integration without any complications. This interoperability ensures that healthcare professionals can leverage Kipuwex within their existing workflows without disruption, maximizing efficiency and effectiveness in patient care.”

The Worlds Times: Can you share any testimonials or case studies from healthcare professionals who have used Kipuwex in their practice?

Marko Höynälä replied, “Product development is at the heart of what we do. We put every effort into ensuring the Kipuwex Remote Monitoring Medical Device meets the highest standards. From concept to creation, our dedicated team has worked tirelessly to bring this cutting-edge technology to life, with a focus on usability, reliability, and effectiveness.

We recently conducted usability testing in Miami, US, with healthcare professionals, and the results were excellent. The feedback we received was positive, with practitioners praising the device for its user-friendly interface, seamless integration into clinical workflows, and, most importantly, its ability to enhance patient care.

As we prepare to enter the US markets this summer, we are incredibly excited about the potential impact of the Kipuwex Remote Monitoring Medical Device. With its advanced features and user-friendly design, we believe it has the power to revolutionize healthcare practices and improve outcomes for patients.”

Future Innovations in Pain Management Technology

The Worlds Times: What are the future developments or enhancements planned for Kipuwex to further improve its functionality and impact on pain management?

Marko Höynälä replied, “We’re excited and honored to be part of the first-ever Match Play Challenge program in US and as only company out of US. Being selected for this pioneering initiative is a testament to our commitment to making a meaningful impact in pain management. During this 3 months program we are focusing to transform pain measurement technology together.”

Discover Kipuwex at HLTH Exhibition in Las Vegas October 20-23!

Lastly we asked, “Would you like to say anything else to our viewers?”

“We were attending to FIME Exhibition in Miami June 19-21, which was a great success for us. We gained interest from over 20 new countries seeking to become distributors of Kipuwex. Next we are inviting all to discover our revolutionary medical device for remote monitoring at the HLTH Exhibition in Las Vegas October 20-23, 2024.

We are excited to announce that we are bringing Kipuwex to the market, immediately when we secure FDA approval for the United States during this summer. Following this, we will promptly seek MDR certification for Europe.

Currently, we are actively seeking partners to collaborate on clinical trials. Additionally, we are looking for global distributors to help bring Kipuwex to markets around the world.

If you are interested in partnering with us for clinical trials or in becoming a distributor, we would love to hear from you. Together, we can make a significant impact on healthcare globally.” Marko Höynälä concluded

Connect Marko Höynälä on Linkedin

Visit Kipuwex to learn more about it

Read more interview here: https://www.theworldstimes.com/interviews/